Skip to content

Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks

Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02852096
Enrollment
600
Registered
2016-08-02
Start date
2015-11-30
Completion date
2019-12-31
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer, HER-2

Keywords

gastric cancer, Her2/neu, dual paraffin blocks, trastuzumab

Brief summary

One paraffin block is routinely used for Human Epidermal Growth Factor Receptor 2 (Her2/neu) immunohistochemistry (IHC) assessment. Here, investigators investigated if picking two or multiple paraffin blocks for Her2/neu evaluation is an economical, efficient and practical method, which may reduce false-negativity of Her2/neu IHC assessment due to intratumoral heterogeneity.

Interventions

OTHERDual or Multiple Paraffin Blocks

Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks

OTHEROne Paraffin Blocks

Assessing Her2/Neu Expression in Gastric Cancer With One Tumor Tissue Paraffin Blocks

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Age between 18 to 80; Received curative surgery with primary gastric adenocarcinoma; Did not receive any preoperative treatment.

Exclusion criteria

None.

Design outcomes

Primary

MeasureTime frame
The positive rate of cohort using dual or multiple tumor tissue paraffin blocks24 months

Countries

China

Contacts

Primary ContactYingyong Hou, M.D. & Ph.D.
hou.yingyong@zs-hospital.sh.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026